Affinia Therapeutics
Affinia Therapeutics is a biotechnology company developing transformative AAV gene therapies for people with devastating diseases.
Affinia Therapeutics is a business in biotechnology, health care, life science, therapeutics based in Greater Boston Area, East Coast, New England, Northeastern US, founded in 2019.
Its activity falls under biotechnology, health care, life science, therapeutics; the profile below is assembled from public directory data.
Greater Boston Area, East Coast, New England, Northeastern US is where the company is located.
It is recorded at the Series_B stage.
Recorded headcount: c_00051_00100 employees.
Total disclosed funding stands at about $170M.
| Sector | Biotechnology, Health Care, Life Science, Therapeutics |
|---|---|
| Headquarters | Greater Boston Area, East Coast, New England, Northeastern US |
| Country | United States |
| Founded | 2019 |
| Employees | c_00051_00100 |
| Stage | series_b |
| Total funding | $170,000,000 |
Website: www.affiniatx.com
Browse related
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account